Abstract
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primary Objective To evaluate the effects of renin‐angiotensin system (RAS) inhibitors in the treatment of adult patients with COVID‐19 on total serious adverse events (TSAEs) at any stage of the illness. Secondary Objectives To evaluate the effects of RAS inhibitors in the treatment of adult patients with COVID‐19 on hospitalization duration and invasive mechanical ventilation duration.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
